Graham Phillips has joined Endologix after an extensive career at Medtronic, Covidien, and Tyco Healthcare, where he most recently served as Vice President of Manufacturing for the Americas East Region. He oversaw operations across 25 manufacturing sites from Canada to Brazil, including the Caribbean, Midwest, and U.S. East Coast, contributing significantly to the company’s operational success.
Before his time in medical devices, Graham held management roles at Budelpack and Kraft Foods. His academic background includes a Mechanical Engineering degree from the University of Teesside, UK, an MBA from the University of Warwick Business School, UK, and an Advanced Management qualification from Chicago Booth Business School. He is also a Chartered Engineer with the UK Institute of Mechanical Engineers and holds a Six Sigma Black Belt.
As Endologix’s new COO, Graham will oversee manufacturing, supply chain, R&D, and quality, reporting directly to Matt Thompson, MD, President, and CEO. Matt Thompson praised Graham’s leadership and operational expertise, highlighting their importance for driving growth and innovation at Endologix.
Graham Phillips expressed excitement about joining Endologix, emphasizing his goal to leverage operational management experience to enhance patient care through innovation in manufacturing and R&D processes. Endologix, based in California, focuses on developing innovative therapies for vascular disease, with products like the AFX®2 Endovascular AAA System and ALTO® Abdominal Stent Graft System.
